Abstract

Carbapenem-Resistant Gram-Negative Pathogens Among Hospitalized Patients in the United States Between 2010 and 2015

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Impact of bloodstream infections caused by carbapenem-resistant Gram-negative pathogens on ICU costs, mortality and length of stay
E Kousouli ... S Pournaras
Infection Prevention in Practice | VOL. 1
E Kousouli, et. al.E Kousouli ... S Pournaras
01 Jun 2019
In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.
Christopher Longshaw ... Laurent Dortet
Antibiotics (Basel, Switzerland) | VOL. 11
Christopher Longshaw, et. al.Christopher Longshaw ... Laurent Dortet
04 Oct 2022
The role of infection control in curbing Carbapenem resistance
A Apisarnthanarak
International Journal of Infectious Diseases | VOL. 16
A ApisarnthanarakA Apisarnthanarak
01 Jun 2012
165. Cefiderocol Treatment for Serious Infections Caused by Carbapenem-resistant Bacteria: Post-hoc Analysis of Outcomes by Pathogen in the CREDIBLE-CR Study
Kiichiro Toyoizumi ... Tsutae Den Nagata
Open Forum Infectious Diseases | VOL. 7
Kiichiro Toyoizumi, et. al.Kiichiro Toyoizumi ... Tsutae Den Nagata
31 Dec 2020
View more papers

More From: Open Forum Infectious Diseases

Paper Title
Journal
Date
Author
Tailoring interventions for control of endemic carbapenem-resistant Acinetobacter baumannii: an interrupted time series analysis
Vered Schechner ... Yehuda Carmeli
Open Forum Infectious Diseases | VOL. -
Vered Schechner, et. al.Vered Schechner ... Yehuda Carmeli
28 May 2024
Post coronary artery bypass graft deep sternal wound infection caused by Rhizopus species
Cody A Cunningham ... Janis E Blair
Open Forum Infectious Diseases | VOL. -
Cody A Cunningham, et. al.Cody A Cunningham ... Janis E Blair
28 May 2024
Cabotegravir + Rilpivirine Long-Acting: Overview of Injection Guidance, Injection Site Reactions, and Best Practices for Intramuscular Injection Administration
Paula Teichner ... Jean Van Wyk
Open Forum Infectious Diseases | VOL. -
Paula Teichner, et. al.Paula Teichner ... Jean Van Wyk
25 May 2024
Review of the in vitro microbiological activity of mecillinam against common uropathogens in uncomplicated urinary tract infection (uUTI): focus on resistant pathogens
Tom P Lodise ... Gunnar Kahlmeter
Open Forum Infectious Diseases | VOL. -
Tom P Lodise, et. al.Tom P Lodise ... Gunnar Kahlmeter
24 May 2024
View more papers